Jacek Jassem

机构：Gdańsk Medical University · ORCID：0000-0002-8875-6747

发表论文 1024 篇 · 总被引 56717 次 · h-index 87

代表论文

• First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial (2026 · Nature Cancer · 被引 1)
• Polish consensus on smoking cessation intervention within lung cancer screening (2025 · Archives of Medical Science · 被引 1)
• Supplementary Figure S4 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
• Supplementary Table S7 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
• Table 2 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
• Table 1 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)